“PARP Inhibitors in Newly Diagnosed or Recurrent Ovarian Cancer Maintenance Therapy: Evidence of Efficacy and Safety from Randomized Controlled Trials”. Biomedical Research and Therapy, vol. 10, no. 12, Dec. 2023, pp. 6090-02, https://doi.org/10.15419/bmrat.v10i12.851.